Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)	3 Months Ended		99 Months Ended
	Jan. 31, 2014	Jan. 31, 2013	Jan. 31, 2014
Cash flows from operating activities:
Net loss	$ (573,833)	$ (295,070)	$ (19,174,463)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	15,654	12,764	280,528
Gain on extinguishment of debt			(288,192)
Change in value of derivatives	(8,763)		(166,820)
Change in anti-dilution liability	(3,271)		(45,314)
Amortization of costs and fees related to convertible debentures	35,114	5,057	1,377,651
Common stock issued for services			2,144,790
Common stock issued to officers, directors and consultants for services			3,212,484
Common stock issued for shares of subsidiary stock			254,000
Common stock of subsidiary issued to employees and consultants			2,815
Common stock issued as a commission			3,000
Common stock issued for accounts payable			296,583
Common stock issued to former licensee			41,319
Common stock issued/recovered on cancelled agreements			20,478
Non-cash compensation for stock options and warrants	260,282		892,205
Costs and fees related to issuance of convertible debt			542,540
Interest expense related to beneficial conversion feature			1,942,820
Interest paid with common stock			118,487
Interest on notes receivable for common stock			(1,373)
(Increase) decrease in assets:
Related party receivables		3,254
Prepaid expenses	(2,031)	14,979	22,663
Inventories		(41,887)	(143,275)
Increase (decrease) in liabilities:
Trade accounts payable	20,887	57,165	690,575
Accounts payable to officers and directors	24,517	16,635	863,029
Accrued payroll and other expenses	75,224	20,933	637,623
Net cash used in operating activities	(156,220)	(206,170)	(6,475,847)
Cash flows from investing activities:
Purchase of fixed assets	(1,270)	(3,500)	(260,130)
Capitalization of software			(35,313)
Net cash used in investing activities	(1,270)	(3,500)	(295,443)
Cash flows from financing activities:
Bank overdraft	5,983		5,983
Principal payments on notes payable to stockholder		(22,500)	(1,301,800)
Proceeds from issuance of notes payable to a related party	34,000		1,194,600
Proceeds from issuance of notes and convertible notes payable	32,500		1,721,734
Proceeds from issuance of common stock	80,000	145,000	3,955,475
Net cash provided by financing activities	152,483	122,500	5,575,992
Net change in cash	(5,007)	(87,170)	(1,195,298)
Cash at beginning of period	5,007	90,132	1,195,298
Cash at end of period		2,962
Supplemental Disclosure of Cash Flow Information
Interest paid
Income taxes paid		1,600
Supplemental Schedule of Non-Cash Investing and Financing Activities
Conversion of convertible notes payable to shares of common stock	15,000
Common stock issued in consideration for accounts payable and accrued payroll		$ 12,000